Evaluation of Suspected Hypersensitivity Reactions to Oral Iron Preparations in Children.

IF 2.3 4区 医学 Q3 ALLERGY
Deniz Yilmaz, Ahmet Selmanoglu, Zeynep Sengül Emeksiz, Emine Dibek Misirlioglu
{"title":"Evaluation of Suspected Hypersensitivity Reactions to Oral Iron Preparations in Children.","authors":"Deniz Yilmaz, Ahmet Selmanoglu, Zeynep Sengül Emeksiz, Emine Dibek Misirlioglu","doi":"10.1159/iaa/adfag038","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Oral iron preparations are widely used in the treatment of iron deficiency anemia globally, including children. Although adverse reactions are occasionally reported, true hypersensitivity to oral iron is considered uncommon. However, suspected reactions may lead to unnecessary discontinuation of iron therapy and referral to allergy clinics. To evaluate the clinical characteristics and diagnostic yield of drug provocation testing in children with suspected hypersensitivity reactions to oral iron preparations.</p><p><strong>Methods: </strong>This retrospective study included children referred to a tertiary pediatric allergy clinic for suspected hypersensitivity to oral iron preparations. Clinical characteristics, reaction phenotypes, timing of reactions, and drug provocation test (DPT) outcomes were analyzed. Hypersensitivity was confirmed when objective symptoms were reproduced during culprit drug provocation. Children aged 0-18 years who underwent culprit or alternative drug provocation testing were included.</p><p><strong>Results: </strong>A total of 28 children were included in the analysis. The median age at the index reaction was 2.5 years (IQR: 0.5-9.3), and 18 patients (64.3%) were female. Allergic diseases were present in 12 patients (42.9%). Maculopapular eruption was the most frequently reported index reaction (11/28, 39.3%), followed by other cutaneous rashes (6/28, 21.4%), urticaria (5/28, 17.9%), and angioedema (1/28, 3.6%) while non-cutaneous manifestations were reported in 5 patients (17.9%). The median time from drug intake to symptom onset was 6.75 hours (IQR: 4.12-9.00). Culprit drug provocation testing was performed in 14 patients, confirming hypersensitivity in 2 cases (2/14, 14.3%). Twelve patients (12/14, 85.7%) had negative provocation tests. Alternative iron provocation was performed in 14 patients; all of which were tolerated.</p><p><strong>Conclusion: </strong>True hypersensitivity to oral iron preparations appears to be uncommon in children. Appropriate allergy evaluation, including drug provocation testing when indicated, may help clarify suspected reactions and prevent unnecessary avoidance of iron therapy.</p>","PeriodicalId":13652,"journal":{"name":"International Archives of Allergy and Immunology","volume":" ","pages":"1"},"PeriodicalIF":2.3000,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Archives of Allergy and Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/iaa/adfag038","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Oral iron preparations are widely used in the treatment of iron deficiency anemia globally, including children. Although adverse reactions are occasionally reported, true hypersensitivity to oral iron is considered uncommon. However, suspected reactions may lead to unnecessary discontinuation of iron therapy and referral to allergy clinics. To evaluate the clinical characteristics and diagnostic yield of drug provocation testing in children with suspected hypersensitivity reactions to oral iron preparations.

Methods: This retrospective study included children referred to a tertiary pediatric allergy clinic for suspected hypersensitivity to oral iron preparations. Clinical characteristics, reaction phenotypes, timing of reactions, and drug provocation test (DPT) outcomes were analyzed. Hypersensitivity was confirmed when objective symptoms were reproduced during culprit drug provocation. Children aged 0-18 years who underwent culprit or alternative drug provocation testing were included.

Results: A total of 28 children were included in the analysis. The median age at the index reaction was 2.5 years (IQR: 0.5-9.3), and 18 patients (64.3%) were female. Allergic diseases were present in 12 patients (42.9%). Maculopapular eruption was the most frequently reported index reaction (11/28, 39.3%), followed by other cutaneous rashes (6/28, 21.4%), urticaria (5/28, 17.9%), and angioedema (1/28, 3.6%) while non-cutaneous manifestations were reported in 5 patients (17.9%). The median time from drug intake to symptom onset was 6.75 hours (IQR: 4.12-9.00). Culprit drug provocation testing was performed in 14 patients, confirming hypersensitivity in 2 cases (2/14, 14.3%). Twelve patients (12/14, 85.7%) had negative provocation tests. Alternative iron provocation was performed in 14 patients; all of which were tolerated.

Conclusion: True hypersensitivity to oral iron preparations appears to be uncommon in children. Appropriate allergy evaluation, including drug provocation testing when indicated, may help clarify suspected reactions and prevent unnecessary avoidance of iron therapy.

儿童口服铁制剂疑似超敏反应的评价。
口服铁制剂在全球范围内广泛用于治疗缺铁性贫血,包括儿童。虽然偶尔有不良反应的报道,但对口服铁的真正过敏被认为是罕见的。然而,疑似反应可能导致不必要的铁治疗中断和转介到过敏诊所。目的探讨口服铁制剂疑似超敏反应患儿药物激发试验的临床特点及诊断率。方法:本回顾性研究纳入了因怀疑对口服铁制剂过敏而转诊至三级儿科过敏诊所的儿童。分析临床特征、反应表型、反应时间和药物激发试验(DPT)结果。当在元凶药物刺激过程中再现客观症状时,证实过敏。研究对象为0-18岁的儿童,均进行了罪犯或替代药物激发试验。结果:共有28名儿童被纳入分析。指数反应发生时的中位年龄为2.5岁(IQR: 0.5 ~ 9.3),女性18例(64.3%)。过敏性疾病12例(42.9%)。黄斑丘疹是最常见的指数反应(11/28,39.3%),其次是其他皮疹(6/28,21.4%)、荨麻疹(5/28,17.9%)和血管性水肿(1/28,3.6%),5例患者报告非皮肤表现(17.9%)。从药物摄入到出现症状的中位时间为6.75小时(IQR: 4.12-9.00)。14例患者行罪魁祸首药物激发试验,2例(2/14,14.3%)确认过敏。12例(12/14,85.7%)激发试验阴性。14例患者进行了替代铁激发;所有这些都是可以容忍的。结论:口服铁制剂的真正超敏反应在儿童中并不常见。适当的过敏评估,包括药物激发试验,可能有助于澄清可疑的反应,并防止不必要的铁治疗回避。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.60
自引率
3.60%
发文量
105
审稿时长
2 months
期刊介绍: ''International Archives of Allergy and Immunology'' provides a forum for basic and clinical research in modern molecular and cellular allergology and immunology. Appearing monthly, the journal publishes original work in the fields of allergy, immunopathology, immunogenetics, immunopharmacology, immunoendocrinology, tumor immunology, mucosal immunity, transplantation and immunology of infectious and connective tissue diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书